Diverse antidepressants increase CDP-diacylglycerol production and phosphatidylinositide resynthesis in depression-relevant regions of the rat brain

BMC Neuroscience

Volumn 9, Issue , 2008, Pages

  Tyeryar, Kimberly R ^b   Vongtau, Habiba O U ^b   Undieh, Ashiwel S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZATROPINE; CHLORPROMAZINE; CYTIDINE DIPHOSPHATE DIGLYCERIDE; DESIPRAMINE; DIAZEPAM; FLUOXETINE; FLUPENTIXOL; GLYCEROPHOSPHOLIPID; HALOPERIDOL; HYDROXYLAMINE; IMIPRAMINE; LITHIUM; MAPROTILINE; MEPACRINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NITRAZEPAM; NOMIFENSINE; PARGYLINE; PAROXETINE; PHENYLEPHRINE; PHENYTOIN; PHOSPHATIDYLINOSITIDE; PSYCHOTROPIC AGENT; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; UNINDEXED DRUG; PHOSPHATIDYLINOSITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; HIPPOCAMPUS; HYDROLYSIS; LIPOGENESIS; MALE; NONHUMAN; PATHOGENESIS; POSTSYNAPTIC INHIBITION; RAT; SPRAGUE DAWLEY RAT; STRIATE CORTEX; ANIMAL; BRAIN; BRAIN LEVEL; DOSE RESPONSE; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN CHEMISTRY; CYTIDINE DIPHOSPHATE DIGLYCERIDES; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PHOSPHATIDYLINOSITOLS; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 39449120454     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-9-12     Document Type: Article

References (80)

1. Waslick BD Kandel R Kakouros A Depression in children and adolescents: an overview The many faces of depression in children and adolescents Washington DC, American Psychiatric Publishing, Inc. Shaffer D and Waslick BD 2002:1-29.
2. Costello EJ Mustillo S Erkanli A Keeler G Angold A Prevalence and development of psychiatric disorders in childhood and adolescence Arch Gen Psychiatry 2003, 60:837-844. 10.1001/archpsyc.60.8.837 12912767
3. Hasin DS Goodwin RD Stinson FS Grant BF Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcoholism and Related Conditions Arch Gen Psychiatry 2005, 62:1097-1106. 10.1001/ archpsyc.62.10.1097 16203955
4. Ciraulo DA Tsirulnik-Barts L Shader RI Greenblatt DJ Clinical pharmacology and therapeutics of antidepressants Pharmacotherapy of depression Totowa NJ, Humana Press Ciraulo DA and Shader RI 2004:33-119.
5. Taylor C Fricker AD Devi LA Gomes I Mechanisms of action of antidepressants: From neurotransmitter systems to signaling pathways Cell Signal 2005, 17:549-557. 10.1016/j.cellsig.2004.12.007 15683730
6. Feighner JP Mechanism of action of antidepressant medications J Clin Psychiatry 1999, 60:4-11. 10086478
7. Frazer A Norepinephrine involvement in antidepressant action J Clin Psychiatry 2000, 61:25-30. 10910014
8. Gould TD Manji HK Signaling networks in the pathophysiology and treatment of mood disorders J Psychosom Res 2002, 53:687-697. 10.1016/ S0022-3999(02)00426-9 12169343
9. Coyle JT Duman RS Finding the intracellular signaling pathways affected by mood disorder treatments Neuron 2003, 38:157-160. 10.1016/ S0896-6273(03)00195-8 12718851
10. Delgado PL How antidepressants help depression: Mechanisms of action and clinical response J Clin Psychiatry 2004, 65:25-30. 15046538
11. De Vivo M Maayani S Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes J Pharmacol Exp Ther 1986, 238:248-253. 2941565
12. De Vivo M Maayani S Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors Biochem Pharmacol 1990, 40:1551-1558. 10.1016/0006-2952(90)90453-R 2222510
13. Dumuis A Sebben M Bockaert J Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture Mol Pharmacol 1988, 33:178-186. 2828913
14. Undie AS Weinstock J Sarau HM Friedman E Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain J Neurochem 1994, 62:2045-2048. 7908949
15. Dwivedi Y Agrawal AK Rizavi HS Pandey GN Antidepressants reduce phosphoinositide-specific phospholipase C (PI-PLC) activity and the mRNA and protein expression of selective PLC beta 1 isozyme in rat brain Neuropharmacology 2002, 43:1269-1279. 10.1016/S0028-3908(02)00253-8 12527476
16. Fumagalli F Molteni R Calabrese F Frasca A Racagni G Riva MA Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain J Neurochem 2005, 93:1551-1560. 10.1111/ j.1471-4159.2005.03149.x 15935071
17. Chen J Rasenick MM Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content J Pharmacol Exp Ther 1995, 275:509-517. 7562593
18. Hines LM Tabakoff B Platelet adenylyl cyclase activity: A biological marker for major depression and recent drug use Biol Psychiatry 2005, 58:955-962. 10.1016/j.biopsych.2005.05.040 16095566
19. Odagaki Y Garcia-Sevilla JA Huguelet P La Harpe R Koyama T Guimon J Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims Brain Res 2001, 898:224-231. 10.1016/S0006-8993(01)02188-6 11306008
20. Shimizu M Nishida A Zensho H Yamawaki S Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor- mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes J Pharmacol Exp Ther 1996, 279:1551-1558. 8968382
21. Qu Y Chang L Klaff J Seemann R Rapoport SI Imaging brain phospholipase A2-mediated signal transduction in response to acute fluoxetine administration in unanesthetized rats Neuropsychopharmacology 2003, 28:1219-1226. 10.1038/sj.npp.1300177 12784122
22. Nibuya M Nestler EJ Duman RS Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus J Neurosci 1996, 16:2365-2372. 8601816
23. Yamada S Yamamoto M Ozawa H Riederer P Saito T Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder J Neural Transm 2003, 110:671-680. 10.1007/s00702-002-0810-8 12768362
24. Fukuda H Nishida A Saito H Shimizu M Yamawaki S Imipramine stimulates phospholipase C activity in rat brain Neurochem Int 1994, 25:567-571. 10.1016/0197-0186(94)90155-4 7894333
25. Pacheco MA Stockmeier C Meltzer HY Overholser JC Dilley GE Jope RS Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain Brain Res 1996, 723:37-45. 10.1016/ 0006-8993(96)00207-7 8813380
26. Butler PD Barkai AI Agonist-stimulation of cerebral phosphoinositide turnover following long-term treatment with antidepressants Adv Exp Med Biol 1987, 221:531-547. 2829591
27. Osborne NN Tricyclic antidepressants, mianserin, and ouabain stimulate inositol phosphate formation in vitro in rat cortical slices Neurochem Res 1988, 13:105-111. 10.1007/BF00973321 3362289
28. Sanders-Bush E Breeding M Knoth K Tsutsumi M Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system Psychopharmacology (Berlin) 1989, 99:64-69. 10.1007/BF00634454
29. Pandey GN Pandey SC Davis JM Effect of desipramine on inositol phosphate formation and inositol phospholipids in rat brain and human platelets Psychopharmacol Bull 1991, 27:255-261. 1775595
30. Pandey SC Davis JM Schwertz DW Pandey GN Effect of antidepressants and neuroleptics on phosphoinositide metabolism in human platelets J Pharmacol Exp Ther 1991, 256:1010-1018. 1672374
31. Morishita S Aoki S Watanabe S Different effect of desipramine on protein kinase C in platelets between bipolar and major depressive disorders Psychiatry Clin Neurosci 1999, 53:11-15. 10.1046/ j.1440-1819.1999.00479.x 10201278
32. Morishita S Aoki S Effects of tricyclic antidepressants on protein kinase C activity in rabbit and human platelets in vivo J Affect Disord 2002, 70:329-332. 10.1016/S0165-0327(01)00333-0 12128246
33. Mann CD Vu TB Hrdina PD Protein kinase C in rat brain cortex and hippocampus: Effect of repeated administration of fluoxetine and desipramine Br J Pharmacol 1995, 115:595-600. 1908484 7582477
34. Einat H Yuan P Gould TD Li J Du J Zhang L Manji HK Chen G The role of the extracellular signal-regulated kinase signaling pathway in mood modulation J Neurosci 2003, 23:7311-7316. 12917364
35. M Nishida A Hayakawa H Yamawaki S Ca2+ release from inositol 1,4,5-trisphosphate-sensitive Ca2+ store by antidepressant drugs in cultured neurons of rat frontal cortex J Neurochem 1993, 60:595-601. 10.1111/j.1471-4159.1993.tb03190.x 8419538
36. Cuellar-Quintero JL Garcia DE Cruzblanca H The antidepressant imipramine inhibits the M-type K+ current in rat sympathetic neurons Neuroreport 2001, 12:2195-2198. 10.1097/00001756-200107200-00030 11447333
37. Coppell AL Pei Q Zetterstrom TS Bi-phasic change in BDNF gene expression following antidepressant drug treatment Neuropharmacology 2003, 44:903-910. 10.1016/S0028-3908(03)00077-7 12726822
38. Saarelainen T Hendolin P Lucas G Koponen E Sairanen M MacDonald E Agerman K Haapasalo A Nawa H Aloyz R Ernfors P Castren E Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects J Neurosci 2003, 23:349-357. 12514234
39. Xu H Steven RJ Li XM Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus Neuropsychopharmacology 2003, 28:53-62. 10.1038/sj.npp.1300009 12496940
40. Wong ML Khatri P Licinio J Esposito A Gold PW Identification of hypothalamic transcripts upregulated by antidepressants Biochem Biophys Res Commun 1996, 229:275-279. 10.1006/bbrc.1996.1792 8954118
41. Manev R Uz T Manev H Fluoxetine increases the content of neurotrophic protein S100beta in the rat hippocampus Eur J Pharmacol 2001, 420:R1-R2. 10.1016/S0014-2999(01)00989-X 11408041
42. Dziedzicka-Wasylewska M Dlaboga D Pierzchala-Koziec K Rogoz Z Effect of tianeptine and fluoxetine on the levels of Met-enkephalin and mRNA encoding proenkephalin in the rat J Physiol Pharmacol 2002, 53:117-125. 11939714
43. Duman RS Nakagawa S Malberg J Regulation of adult neurogenesis by antidepressant treatment Neuropsychopharmacology 2001, 25:836-844. 10.1016/S0893-133X(01)00358-X 11750177
44. Malberg JE Eisch AJ Nestler EJ Duman RS Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus J Neurosci 2000, 20:9104-9110. 11124987
45. Manev H Uz T Smalheiser NR Manev R Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro Eur J Pharmacol 2001, 411:67-70. 10.1016/S0014-2999(00)00904-3 11137860
46. Santarelli L Saxe M Gross C Surget A Battaglia F Dulawa S Weisstaub N Lee J Duman R Arancio O Belzung C Hen R Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants Science 2003, 301:805-809. 10.1126/science.1083328 12907793
47. Contreras CM Rodriguez-Landa JF Gutierrez-Garcia AG Bernal-Morales B The lowest effective dose of fluoxetine in the forced swim test significantly affects the firing rate of lateral septal nucleus neurones in the rat J Psychopharmacol 2001, 15:231-236. 11769815
48. Dong J Blier P Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment Psychopharmacology (Berl) 2001, 155:52-57. 10.1007/s002130000665 11374336
49. Langosch JM Walden J Effects of the atypical antidepressant trimipramine on neuronal excitability and long-term potentiation in guinea pig hippocampal slices Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:299-302. 10.1016/S0278-5846(01)00269-X 11817507
50. Lesch KP Manji HK Signal-transducing G proteins and antidepressant drugs: Evidence for modulation of alpha subunit gene expression in rat brain Biol Psychiatry 1992, 32:549-579. 10.1016/0006-3223(92)90070-G 1333286
51. Drigues N Poltyrev T Bejar C Weinstock M Youdim MB cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs J Neural Transm 2003, 110:1413-1436. 10.1007/s00702-003-0077-8 14666413
52. Landgrebe J Welzl G Metz T van Gaalen MM Ropers H Wurst W Holsboer F Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling J Psychiatr Res 2002, 36:119-129. 10.1016/S0022-3956(01)00061-9 11886689
53. Palotas M Palotas A Puskas LG Kitajka K Pakaski M Janka Z Molnar J Penke B Kalman J Gene expression profile analysis of the rat cortex following treatment with imipramine and citalopram Int J Neuropsychopharmacol 2004, 7:401-413. 10.1017/S1461145704004493 15315716
54. Coupland NJ Ogilvie CJ Hegadoren KM Seres P Hanstock CC Allen PS Decreased prefrontal Myo-inositol in major depressive disorder Biol Psychiatry 2005, 57:1526-1534. 10.1016/j.biopsych.2005.02.027 15953489
55. Barkai AI Dunner DL Gross HA Mayo P Fieve RR Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder Biol Psychiatry 1978, 13:65-72. 623854
56. Einat H Karbovski H Korik J Tsalah D Belmaker RH Inositol reduces depressive-like behaviors in two different animal models of depression Psychopharmacology (Berl) 1999, 144:158-162. 10.1007/s002130050989 10394997
57. Einat H Clenet F Shaldubina A Belmaker RH Bourin M The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors Behav Brain Res 2001, 118:77-83. 10.1016/S0166-4328(00)00314-4 11163636
58. Levine J Controlled trials of inositol in psychiatry Eur Neuropsychopharmacol 1997, 7:147-155. 10.1016/S0924-977X(97)00409-4 9169302
59. Manji HK Chen G Post-receptor signaling pathways in the pathophysiology and treatment of mood disorders Curr Psychiatry Rep 2000, 2:479-489. 10.1007/s11920-000-0006-6 11122999
60. Shelton RC Intracellular mechanisms of antidepressant drug action Harv Rev Psychiatry 2000, 8:161-174. 10.1093/hrp/8.4.161 11038341
61. Nishizuka Y Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C Science 1992, 258:607-614. 10.1126/ science.1411571 1411571
62. Sarri E Picatoste F Claro E Neurotransmitter-specific profiles of inositol phosphates in rat brain cortex: Relation to the mode of receptor activation of phosphoinositide phospholipase C1 The Journal of Pharmacology and Experimental Therapeutics 1995, 272:77-84.
63. Claro E Fain JN Picatoste F Noradrenaline stimulation unbalances the phosphoinositide cycle in rat cerebral cortical slices J Neurochem 1993, 60:2078-2086. 10.1111/j.1471-4159.1993.tb03492.x 8388033
64. Tyeryar KR Undie AS Diverse antidepressants modulate one or more components of phosphoinositide signaling cascades in depression-relevant brain regions Soc Neurosci Abstr 2002, 27:306.
65. Undie AS Friedman E Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain J Pharmacol Exp Ther 1990, 253:987-992. 1972756
66. Pandey GN Dwivedi Y Kumari R Janicak PG Protein kinase C in platelets of depressed patients Biol Psychiatry 1998, 44:909-911. 10.1016/ S0006-3223(97)00535-0 9807646
67. Lucki I Singh A Kreiss DS Antidepressant-like behavioral effects of serotonin receptor agonists Neurosci Biobehav Rev 1994, 18:85-95. 10.1016/0149-7634(94)90039-6 8170624
68. Cryan JF Lucki I Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors J Pharmacol Exp Ther 2000, 295:1120-1126. 11082448
69. D'Aquila PS Collu M Pani L Gessa GL Serra G Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression Eur J Pharmacol 1994, 262:107-111. 10.1016/ 0014-2999(94)90033-7 7813561
70. Tyeryar KR Undie AS Tandem regulation of phosphoinositide signaling and acute behavioral effects induced by antidepressant agents in rats Psychopharmacology (Berl) 2007, 193:271-282. 10.1007/s00213-007-0784-1 17435992
71. Downes CP Carter AN Phosphoinositide 3-kinase: A new effector in signal transduction? Cell Signal 1991, 3:501-513. 10.1016/0898-6568(91)90027-R 1664737
72. Daw MI Bortolotto ZA Saulle E Zaman S Collingridge GL Isaac JT Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression Nat Neurosci 2002, 5:835-836. 10.1038/ nn903 12161757
73. Edstrom A Ekstrom PA Role of phosphatidylinositol 3-kinase in neuronal survival and axonal outgrowth of adult mouse dorsal root ganglia explants J Neurosci Res 2003, 74:726-735. 10.1002/jnr.10686 14635223
74. Hsiung SC Adlersberg M Arango V Mann JJ Tamir H Liu KP Attenuated 5-HT1A receptor signaling in brains of suicide victims: Involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase J Neurochem 2003, 87:182-194. 10.1046/ j.1471-4159.2003.01987.x 12969265
75. Undie AS Relationship between dopamine agonist stimulation of inositol phosphate formation and cytidine diphosphate-diacylglycerol accumulation in brain slices Brain Res 1999, 816:286-294. 10.1016/ S0006-8993(98)01076-2 9878788
76. Panchalingam S Undie AS SKF83959 exhibits biochemical agonism by stimulating phosphoinositide hydrolysis and [35S]GTPgS binding in rat and monkey brain Neuropharmacology 2001, 40:826-837. 10.1016/ S0028-3908(01)00011-9 11369036
77. Godfrey PP Potentiation by lithium of CMP-phosphatidate formation in carbachol-stimulated rat cerebral-cortical slices and its reversal by myo-inositol Biochem J 1989, 258:621-624. 1138408 2706006
78. Undie AS Friedman E Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain Eur J Pharmacol 1992, 226:297-302. 10.1016/0922-4106(92)90046-X 1327844
79. Stubbs EB Jr. Agranoff BW Lithium enhances muscarinic receptor-stimulated CDP-diacylglycerol formation in inositol-depleted SK-N-SH neuroblastoma cells J Neurochem 1993, 60:1292-1299. 10.1111/ j.1471-4159.1993.tb03289.x 8455027
80. Billah MM Michell RH Stimulation of the breakdown and resynthesis of phosphatidylinositol in rat hepatocytes by angiotensin, vasopressin and adrenaline Biochem Soc Trans 1978, 6:1033-1035. 744314